[Therapeutic renaissance. Biguanides in type-2 diabetes: metformin].
Neye
Holger
H
Institut für Pharmazeutische und Medizinische Chemie Hittorfstr. 58-62, 48149 Münster. Neye@uni-muenster.de
D000818:Animals; D001645:Biguanides / Q000009:adverse effects / Q000493:pharmacokinetics / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy*; D006801:Humans; D007004:Hypoglycemic Agents / Q000009:adverse effects / Q000493:pharmacokinetics / Q000627:therapeutic use*; D008099:Liver / Q000187:drug effects; D008687:Metformin / Q000009:adverse effects / Q000493:pharmacokinetics / Q000627:therapeutic use*
D001645:Biguanides; D007004:Hypoglycemic Agents; D008687:Metformin
Therapeutische Renaissance. Biguanide bei Typ-2-Diabetes: Metformin.